OTC · Liquid · Oral

Pneumonia Nosode

Chlamydia Trachomatis + Chlamydophila Psittaci + Coccidioides Immitis Whole + Coxiella Burnetii + Coxsackievirus A21 + Haemophilus Influenzae + Histoplasma Capsulatum + Human Adenovirus B Serotype 3 + Human Respiratory Syncytial Virus + Influenza A Virus A/Victoria/2454/2019 Ivr-207 (H1n1) Antigen (Formaldehyde Inactivated) + Klebsiella Pneumoniae + Mycobacterium Tuberculosis + Mycoplasma Pneumoniae + Rickettsia Rickettsii + Staphylococcus Aureus + Streptococcus Pyogenes + Streptococcus Viridans Group

1 ACTIVE SUPPLIER — US

openFDA · updated weekly

US1 NDCs
1 active makers

UKComing
soon

CAComing
soon

AUComing
soon

EUComing
soon

ATC—

RxCUI (US)—

US makers1 labelers

Packages1

DEA / ScheduleNone

Medicaid dispensing volume

No Medicaid utilization on record for this drug concept yet. Quarterly volume (CMS State Drug Utilization Data) loads with the utilization ETL.

Who makes it1 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

Labeler	Type	Packages	Status
Professional Complementary Health Formulas	unknown	1	SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.